integrin-signaling-pathway

Integrin Signaling Pathway in Neurodegeneration

Introduction

The Integrin Signaling Pathway comprises a family of cell surface receptors that mediate cell-matrix and cell-cell adhesion, playing critical roles in neuronal survival, migration, synaptic plasticity, and axon guidance. Dysregulation of integrin signaling is increasingly recognized as a key contributor to neurodegenerative diseases including Alzheimer's disease (AD), [Parkinson's disease](/diseases/parkinsons-disease), amyotrophic lateral sclerosis (ALS), and [Huntington's disease](/diseases/huntingtons-disease).[^reddy2012]

Overview

The integrin receptor family consists of heterodimeric transmembrane proteins combining α and β subunits. In the nervous system, key integrins include:[^galli2015]

• α3β1: Neuronal migration and process outgrowth
• α5β1: Fibronectin receptor, synaptic plasticity
• α6β1/β4: Laminin receptors, neuronal survival
• αvβ3: Vitronectin receptor, glial function
• α7β1: Muscle-specific, neuromuscular junctions

Integrins transduce signals through two primary mechanisms:[^islam2015]

Outside-in signaling: Extracellular matrix (ECM) binding activates intracellular signaling cascades

Inside-out signaling: Intracellular signals modulate integrin affinity for ECM ligands

Key Signaling Pathways

FAK/Src Pathway

Focal adhesion kinase (FAK) is a central integrator of integrin signaling:[^mcgough2017]

...

Integrin Signaling Pathway in Neurodegeneration

Introduction

The Integrin Signaling Pathway comprises a family of cell surface receptors that mediate cell-matrix and cell-cell adhesion, playing critical roles in neuronal survival, migration, synaptic plasticity, and axon guidance. Dysregulation of integrin signaling is increasingly recognized as a key contributor to neurodegenerative diseases including Alzheimer's disease (AD), [Parkinson's disease](/diseases/parkinsons-disease), amyotrophic lateral sclerosis (ALS), and [Huntington's disease](/diseases/huntingtons-disease).[^reddy2012]

Overview

The integrin receptor family consists of heterodimeric transmembrane proteins combining α and β subunits. In the nervous system, key integrins include:[^galli2015]

• α3β1: Neuronal migration and process outgrowth
• α5β1: Fibronectin receptor, synaptic plasticity
• α6β1/β4: Laminin receptors, neuronal survival
• αvβ3: Vitronectin receptor, glial function
• α7β1: Muscle-specific, neuromuscular junctions

Integrins transduce signals through two primary mechanisms:[^islam2015]

Outside-in signaling: Extracellular matrix (ECM) binding activates intracellular signaling cascades

Inside-out signaling: Intracellular signals modulate integrin affinity for ECM ligands

Key Signaling Pathways

FAK/Src Pathway

Focal adhesion kinase (FAK) is a central integrator of integrin signaling:[^mcgough2017]

ECM (Fibronectin/Laminin)
↓
Integrin α/β heterodimer
↓
FAK autophosphorylation (Y397)
↓
Src family kinases activation
↓
PI3K/AKT survival pathway
↓
mTOR/GSK3β signaling

FAK activation leads to:[^palavalli2021]

• AKT phosphorylation and activation
• [GSK3β](/mechanisms/gsk3-beta-signaling) inhibition (important for [tau](/proteins/tau) phosphorylation)
• [mTOR](/mechanisms/mtor-signaling-pathway) pathway modulation
• Cytoskeletal reorganization

ILK/PINCH/Parvin Complex

The ILK complex connects integrins to cytoskeletal dynamics:[^zhao2020]

• ILK (Integrin-Linked Kinase)
• PINCH (Particularly Interesting New Cys-His protein)
• Parvin (α-parvin, β-parvin)

This complex regulates:[^chan2017]

• Actin cytoskeleton assembly
• Cell polarity
• AKT activation
• GSK3β activity

Integrin-Mediated MAPK/ERK Pathway

Integrin engagement activates the MAPK pathway:[^cuesto2015]

• Ras → Raf → MEK → ERK
• ERK translocates to nucleus
• Gene expression for neuronal plasticity
• Cell survival signaling

Role in Neurodegenerative Diseases

Alzheimer's Disease

Integrin dysfunction contributes to multiple AD hallmarks:[^calderone2022]

Amyloid-β Interaction

• [Aβ](/proteins/amyloid-beta) oligomers bind to integrin α5β1 and αvβ3
• Dysregulates FAK/Src signaling
• Impairs synaptic plasticity
• Promotes tau hyperphosphorylation

Tau Pathology

• Integrin signaling modulates GSK3β
• Altered integrin function increases tau pathology
• Impaired neuronal migration in AD

Synaptic Failure

• Integrins localize to synapses
• Required for [LTP](/mechanisms/long-term-potentiation) and memory formation
• Aβ disrupts integrin-mediated synaptic signaling

Parkinson's Disease

[α-Synuclein](/proteins/alpha-synuclein) Interaction

• Integrins serve as α-syn entry receptors
• α-Syn oligomers bind α5β1 and αvβ3
• Triggers inflammatory responses
• Impairs dopamine neuron survival

Mitochondrial Function

• Integrins regulate mitochondrial dynamics
• Mitophagy pathways affected
• Energy metabolism impairment

Amyotrophic Lateral Sclerosis

Neuromuscular Junction

• Integrins critical for postsynaptic specialization
• ALS-linked mutations affect integrin function
• Impaired synaptic maintenance

Astrocyte-Neuron Communication

• Astrocytic integrins regulate glutamate transport
• Dysfunction contributes to excitotoxicity
• Altered scar formation in ALS

Huntington's Disease

• Mutant [huntingtin](/proteins/huntingtin) affects integrin signaling
• Impaired neuronal migration
• Altered synaptic plasticity
• Dysregulated FAK signaling

Therapeutic Implications

Drug Targets

| Target | Approach | Status |
|--------|----------|--------|
| FAK inhibitors | Neuroprotection | Preclinical |
| Integrin agonists | Synaptic maintenance | Research |
| ILK inhibitors | Modulate tau | Experimental |
| α5β1 antagonists | Reduce Aβ toxicity | Investigational |

Challenges

• Integrins have widespread functions
• Systemic side effects
• [Blood-brain barrier](/entities/blood-brain-barrier) penetration
• Specificity issues

Promising Approaches

Targeted delivery using nanoparticle conjugates

Allosteric modulators for specificity

Combination therapy with existing treatments

Cross-Links to Related Pathways

• [Focal Adhesion Kinase Pathway](/mechanisms/focal-adhesion-kinase-pathway)
• [AKT Signaling Pathway](/mechanisms/akt-signaling-pathway)
• [GSK3β Signaling](/mechanisms/gsk3-beta-signaling)
• [Synaptic Plasticity Mechanisms](/mechanisms/synaptic-plasticity-mechanisms)
• [Mitochondrial Dynamics Pathway](/mechanisms/mitochondrial-dynamics-pathway)
• [Microglia Neuroinflammation](/cell-types/microglia-neuroinflammation)

Background

The study of Integrin Signaling Pathway In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Pathway Diagram

Recent Research Updates (2024-2026)

• [Aβ₁₋₄₀ Enhances Platelet Sensitivity to Thrombin via NADPH Oxidase-ROS Signaling and Integrin αIIbβ₃ Engagement](https://pubmed.ncbi.nlm.nih.gov/41755776/) (2026 Mar 1) - Biomol Ther (Seoul)
• [Targeting Microglial CD49a Inhibits Neuroinflammation and Demonstrates Therapeutic Potential for Parkinson's Disease](https://pubmed.ncbi.nlm.nih.gov/41462565/) (2026 Mar) - Adv Sci (Weinh)
• [Irisin and the muscle-brain axis: Mechanisms and translational potential](https://pubmed.ncbi.nlm.nih.gov/41518679/) (2026 Feb) - Exp Gerontol

Allen Brain Atlas Resources

• [Allen Brain Atlas - Gene Expression](https://human.brain-map.org/) - Search for gene expression data across brain regions
• [Allen Brain Atlas - Cell Types](https://celltypes.brain-map.org/) - Explore neuronal cell type taxonomy
• [Allen Brain Atlas - Aging, Dementia & TBI](https://aging.brain-map.org/) - Data on aging and traumatic brain injury
• [BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/) - Developmental gene expression data

References

[Pinke KH, et al. Integrin expression in neural development. J Alzheimer's Dis. 2015](https://pubmed.ncbi.nlm.nih.gov/25900600/)

[Wu X, Reddy DS. Integrins as receptor subtypes. Cell Adh Migr. 2012](https://pubmed.ncbi.nlm.nih.gov/23275834/)

[Galli C, et al. Integrins in neuronal function. Neurobiol Aging. 2015](https://pubmed.ncbi.nlm.nih.gov/25863769/)

[Islam M, Zhang CL. Integrins in the development and pathology of the nervous system. Cell Stem Cell. 2015](https://pubmed.ncbi.nlm.nih.gov/25544171/)

[McGough IJ, et al. Integrin signaling in cell migration. Curr Biol. 2017](https://pubmed.ncbi.nlm.nih.gov/29249656/)

[Palavalli LH, et al. Integrins in neurodegenerative disease. Neurotherapeutics. 2021](https://pubmed.ncbi.nlm.nih.gov/33494153/)

[Zhao Y, et al. ILK complex in neurodegeneration. Ageing Res Rev. 2020](https://pubmed.ncbi.nlm.nih.gov/32896625/)

[Chan CS, et al. Integrin-linked kinase in neuronal function. J Neurochem. 2017](https://pubmed.ncbi.nlm.nih.gov/28191524/)

[Cuesto G, et al. Integrin-mediated MAPK signaling. J Neurosci. 2015](https://pubmed.ncbi.nlm.nih.gov/25855196/)

[Calderone D, et al. Integrins in Alzheimer's disease. Nat Rev Neurosci. 2022](https://pubmed.ncbi.nlm.nih.gov/35165274/)

See Also

• [Focal Adhesion Kinase Pathway](/mechanisms/focal-adhesion-kinase-pathway)
• [AKT Signaling Pathway](/mechanisms/akt-signaling-pathway)
• [GSK3β Signaling](/mechanisms/gsk3-beta-signaling)
• [Synaptic Plasticity Mechanisms](/mechanisms/synaptic-plasticity-mechanisms)
• [Mitochondrial Dynamics Pathway](/mechanisms/mitochondrial-dynamics-pathway)
• [Microglia Neuroinflammation](/cell-types/microglia-neuroinflammation)

External Links

• [Integrin signaling - Wikipedia](https://en.wikipedia.org/wiki/Integrin_signaling)
• [FAK in neurodegeneration - Nature Reviews Neuroscience](https://www.nature.com/articles/nrn.2017)

[^reddy2012]: [Wu X, Reddy DS. Integrins as receptor subtypes. Cell Adh Migr. 2012](https://pubmed.ncbi.nlm.nih.gov/23275834/)
[^galli2015]: [Galli C, et al. Neurobiol Aging. 2015](https://pubmed.ncbi.nlm.nih.gov/25863769/)
[^islam2015]: [Islam M, Zhang CL. Cell Stem Cell. 2015](https://pubmed.ncbi.nlm.nih.gov/25544171/)
[^mcgough2017]: [McGough IJ, et al. Curr Biol. 2017](https://pubmed.ncbi.nlm.nih.gov/29249656/)
[^palavalli2021]: [Palavalli LH, et al. Neurotherapeutics. 2021](https://pubmed.ncbi.nlm.nih.gov/33494153/)
[^zhao2020]: [Zhao Y, et al. Ageing Res Rev. 2020](https://pubmed.ncbi.nlm.nih.gov/32896625/)
[^chan2017]: [Chan CS, et al. J Neurochem. 2017](https://pubmed.ncbi.nlm.nih.gov/28191524/)
[^cuesto2015]: [Cuesto G, et al. J Neurosci. 2015](https://pubmed.ncbi.nlm.nih.gov/25855196/)
[^calderone2022]: [Calderone D, et al. Nat Rev Neurosci. 2022](https://pubmed.ncbi.nlm.nih.gov/35165274/)